Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Summary

RATIONALE: Current therapies for children with recurrent/progressive high grade gliomas provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of children with recurrent/progressive high grade gliomas. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) with recurrent/progressive high grade gliomas.

Timeline

Start

1994-04

Primary completion

1998-01

Completion

1998-01

Drugs

Indications